| 30 | Pharmaceutical products |
Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)
$3,740,345,122.00 of HTS Code 30 — pharmaceutical products imported by the US in 2009-01 $4,103,452,363.00 of HTS Code 30 — pharmaceutical products imported by the US in 2009-02 $4,813,197,616.00 of HTS Code 30 — pharmaceutical products imported by the US in 2009-03 $4,644,450,494.00 of HTS Code 30 — pharmaceutical products imported by the US in 2009-04 $4,004,716,250.00 of HTS Code 30 — pharmaceutical products imported by the US in 2009-05 $4,363,732,588.00 of HTS Code 30 — pharmaceutical products imported by the US in 2009-06 $4,669,746,811.00 of HTS Code 30 — pharmaceutical products imported by the US in 2009-07 $4,367,089,741.00 of HTS Code 30 — pharmaceutical products imported by the US in 2009-08 $4,859,105,592.00 of HTS Code 30 — pharmaceutical products imported by the US in 2009-09 $5,160,941,765.00 of HTS Code 30 — pharmaceutical products imported by the US in 2009-10 $5,491,359,456.00 of HTS Code 30 — pharmaceutical products imported by the US in 2009-11 $5,901,267,777.00 of HTS Code 30 — pharmaceutical products imported by the US in 2009-12 $4,867,611,003.00 of HTS Code 30 — pharmaceutical products imported by the US in 2010-01 $4,384,151,998.00 of HTS Code 30 — pharmaceutical products imported by the US in 2010-02 $5,254,133,589.00 of HTS Code 30 — pharmaceutical products imported by the US in 2010-03 $4,452,827,701.00 of HTS Code 30 — pharmaceutical products imported by the US in 2010-04 $5,120,515,571.00 of HTS Code 30 — pharmaceutical products imported by the US in 2010-05 $6,062,982,845.00 of HTS Code 30 — pharmaceutical products imported by the US in 2010-06 $5,343,631,121.00 of HTS Code 30 — pharmaceutical products imported by the US in 2010-07 $6,007,251,123.00 of HTS Code 30 — pharmaceutical products imported by the US in 2010-08 $4,884,230,406.00 of HTS Code 30 — pharmaceutical products imported by the US in 2010-09 $5,189,330,950.00 of HTS Code 30 — pharmaceutical products imported by the US in 2010-10 $5,060,078,557.00 of HTS Code 30 — pharmaceutical products imported by the US in 2010-11 $5,428,697,543.00 of HTS Code 30 — pharmaceutical products imported by the US in 2010-12 $4,630,649,711.00 of HTS Code 30 — pharmaceutical products imported by the US in 2011-01 $5,668,922,009.00 of HTS Code 30 — pharmaceutical products imported by the US in 2011-02 $5,790,304,005.00 of HTS Code 30 — pharmaceutical products imported by the US in 2011-03 $5,660,549,971.00 of HTS Code 30 — pharmaceutical products imported by the US in 2011-04 $5,141,487,811.00 of HTS Code 30 — pharmaceutical products imported by the US in 2011-05 $5,696,324,069.00 of HTS Code 30 — pharmaceutical products imported by the US in 2011-06 $5,005,243,712.00 of HTS Code 30 — pharmaceutical products imported by the US in 2011-07 $6,099,568,818.00 of HTS Code 30 — pharmaceutical products imported by the US in 2011-08 $5,179,784,680.00 of HTS Code 30 — pharmaceutical products imported by the US in 2011-09 $5,400,519,185.00 of HTS Code 30 — pharmaceutical products imported by the US in 2011-10 $5,603,675,215.00 of HTS Code 30 — pharmaceutical products imported by the US in 2011-11 $5,857,716,599.00 of HTS Code 30 — pharmaceutical products imported by the US in 2011-12 $4,885,238,960.00 of HTS Code 30 — pharmaceutical products imported by the US in 2012-01 $4,973,022,599.00 of HTS Code 30 — pharmaceutical products imported by the US in 2012-02 $5,642,149,738.00 of HTS Code 30 — pharmaceutical products imported by the US in 2012-03 $4,785,513,081.00 of HTS Code 30 — pharmaceutical products imported by the US in 2012-04 $6,071,709,071.00 of HTS Code 30 — pharmaceutical products imported by the US in 2012-05 $5,183,830,048.00 of HTS Code 30 — pharmaceutical products imported by the US in 2012-06 $5,278,704,274.00 of HTS Code 30 — pharmaceutical products imported by the US in 2012-07 $5,618,489,504.00 of HTS Code 30 — pharmaceutical products imported by the US in 2012-08 $5,348,240,189.00 of HTS Code 30 — pharmaceutical products imported by the US in 2012-09 $5,302,645,612.00 of HTS Code 30 — pharmaceutical products imported by the US in 2012-10 $5,828,280,621.00 of HTS Code 30 — pharmaceutical products imported by the US in 2012-11 $5,167,606,862.00 of HTS Code 30 — pharmaceutical products imported by the US in 2012-12 $5,312,244,654.00 of HTS Code 30 — pharmaceutical products imported by the US in 2013-01 $4,646,230,585.00 of HTS Code 30 — pharmaceutical products imported by the US in 2013-02
| Top 10 suppliers | |
|---|---|
| Ireland | $46,326,196,888 |
| Germany | $34,865,365,579 |
| Switzerland | $24,318,454,167 |
| Israel | $20,957,790,008 |
| United Kingdom | $20,861,408,620 |
| Subscribers only | $17,261,577,281 |
| Subscribers only | $16,055,251,622 |
| India | $12,203,009,605 |
| Subscribers only | $9,424,658,707 |
| Subscribers only | $7,859,666,900 |
Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)
Ireland exported $46,326,196,888.00 of HTS Code 30 — pharmaceutical products to the US. Germany exported $34,865,365,579.00 of HTS Code 30 — pharmaceutical products to the US. Switzerland exported $24,318,454,167.00 of HTS Code 30 — pharmaceutical products to the US. Israel exported $20,957,790,008.00 of HTS Code 30 — pharmaceutical products to the US. United Kingdom exported $20,861,408,620.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $17,261,577,281.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $16,055,251,622.00 of HTS Code 30 — pharmaceutical products to the US. India exported $12,203,009,605.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $9,424,658,707.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $7,859,666,900.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $7,626,197,019.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $6,629,326,334.00 of HTS Code 30 — pharmaceutical products to the US. Singapore exported $6,053,158,248.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $4,287,879,826.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,611,452,873.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,425,222,005.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,267,193,673.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,224,030,934.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $1,886,254,290.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $1,658,067,208.00 of HTS Code 30 — pharmaceutical products to the US. Mexico exported $1,243,027,391.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $1,068,653,651.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $603,629,803.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $458,972,302.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $448,151,911.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $404,186,341.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $328,614,388.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $178,630,739.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $173,434,128.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $153,726,945.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $143,912,805.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $139,321,812.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $117,008,934.00 of HTS Code 30 — pharmaceutical products to the US. South Africa exported $95,657,855.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $94,035,637.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $89,909,077.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $71,896,679.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $66,633,111.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $36,840,599.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $36,448,993.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $32,425,329.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $20,716,221.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $20,492,934.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $16,455,866.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $15,082,516.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $14,168,356.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $13,172,909.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $8,617,893.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $8,535,130.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $6,800,854.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $6,198,328.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $4,302,238.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $4,099,347.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,733,072.00 of HTS Code 30 — pharmaceutical products to the US. Panama exported $3,288,228.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,034,436.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $2,315,020.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $1,968,610.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $1,882,453.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $1,704,577.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $1,011,333.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $964,669.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $861,786.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $756,056.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $732,361.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $642,770.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $520,009.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $453,820.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $357,430.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $333,753.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $332,690.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $305,391.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $295,031.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $272,863.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $256,591.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $251,404.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $216,844.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $150,609.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $149,318.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $91,016.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $80,271.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $62,127.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $55,815.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $55,315.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $38,342.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $33,108.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $30,550.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $30,239.00 of HTS Code 30 — pharmaceutical products to the US. Sri Lanka exported $29,362.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $29,321.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $28,082.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $26,010.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $24,486.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $21,160.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $18,220.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $17,600.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $16,000.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $10,775.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $9,165.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $8,393.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $7,939.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $7,225.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $7,000.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $6,300.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $5,700.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $5,518.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,910.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,650.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,582.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,535.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,053.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,000.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $2,905.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $2,438.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $2,268.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $1,142.00 of HTS Code 30 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $1,110.00 of HTS Code 30 — pharmaceutical products to the US.
| Subscribers only | 2.0% |
| Subscribers only | 1.5% |
| Subscribers only | 1.3% |
| Subscribers only | 1.3% |
| Subscribers only | 1.1% |
| Subscribers only | 0.7% |
| Subscribers only | 0.6% |
| Canada | 0.5% |
| Austria | 0.2% |
| Finland | 0.1% |
| Subscribers only | -6.9% |
| Subscribers only | -0.6% |
| Subscribers only | -0.4% |
| Subscribers only | -0.4% |
| Subscribers only | -0.2% |
| Subscribers only | -0.2% |
| Subscribers only | -0.2% |
| Norway | -0.1% |
| Japan | -0.1% |
| Hungary | -0.1% |
Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)
A country, available to Panjiva subscribers, increased in shipments of HTS Code 30 — - to the US by 1.962%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 30 — - to the US by 1.544%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 30 — - to the US by 1.302%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 30 — - to the US by 1.276%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 30 — - to the US by 1.135%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 30 — - to the US by 0.702%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 30 — - to the US by 0.563%.
Canada increased in shipments of HTS Code 30 — - to the US by 0.455%.
Austria increased in shipments of HTS Code 30 — - to the US by 0.177%.
Finland increased in shipments of HTS Code 30 — - to the US by 0.102%.
Hungary decreased in shipments of HTS Code 30 — - to the US by -0.056%.
Japan decreased in shipments of HTS Code 30 — - to the US by -0.091%.
Norway decreased in shipments of HTS Code 30 — - to the US by -0.147%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 30 — - to the US by -0.153%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 30 — - to the US by -0.167%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 30 — - to the US by -0.233%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 30 — - to the US by -0.386%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 30 — - to the US by -0.390%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 30 — - to the US by -0.588%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 30 — - to the US by -6.948%.
| 2009 | 2010 | 2011 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| * | País | Share | Trend | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All |
100%
|
37,403 | 41,035 | 48,132 | 46,445 | 40,047 | 43,637 | 46,697 | 43,671 | 48,591 | 51,609 | 54,914 | 59,013 | 48,676 | 43,842 | 52,541 | 44,528 | 51,205 | 60,630 | 53,436 | 60,073 | 48,842 | 51,893 | 50,601 | 54,287 | 46,306 | 56,689 | 57,903 | 56,605 | 51,415 | 56,963 | 50,052 | 60,996 | 51,798 | 54,005 | 56,037 | 58,577 | 48,852 | 49,730 | 56,421 | 47,855 | 60,717 | 51,838 | 52,787 | 56,185 | 53,482 | 53,026 | 58,283 | 51,676 | 53,122 | 46,462 | ||||
| 1. | Ireland |
18%
|
5,698 | 6,628 | 7,691 | 5,382 | 5,148 | 6,087 | 6,609 | 4,611 | 5,813 | 5,534 | 5,934 | 8,498 | 6,233 | 8,156 | 8,642 | 7,002 | 11,464 | 10,357 | 9,439 | 12,511 | 9,007 | 12,185 | 10,516 | 10,060 | 9,031 | 12,349 | 12,738 | 14,731 | 10,520 | 11,722 | 12,792 | 15,935 | 11,360 | 11,928 | 14,218 | 13,716 | 9,949 | 10,299 | 8,327 | 9,488 | 11,434 | 11,714 | 9,139 | 8,551 | 5,644 | 8,629 | 8,484 | 8,462 | 6,175 | 6,720 | |||
| 2. | Germany |
14%
|
4,650 | 6,094 | 5,898 | 6,960 | 5,440 | 5,716 | 7,114 | 6,336 | 6,236 | 6,684 | 7,769 | 7,036 | 4,814 | 4,580 | 6,012 | 5,388 | 7,583 | 6,230 | 5,956 | 7,436 | 6,208 | 5,718 | 6,105 | 6,121 | 4,270 | 7,860 | 6,313 | 6,058 | 6,145 | 6,354 | 6,350 | 8,708 | 7,048 | 7,959 | 7,502 | 9,448 | 8,934 | 7,856 | 9,271 | 6,181 | 9,363 | 6,990 | 7,803 | 8,526 | 12,031 | 7,712 | 9,583 | 6,865 | 8,585 | 6,855 | |||
| 3. | Switzerland |
9%
|
2,726 | 1,678 | 2,169 | 2,541 | 3,895 | 2,667 | 3,334 | 3,852 | 2,904 | 5,001 | 3,957 | 4,485 | 3,718 | 3,307 | 4,511 | 4,014 | 4,013 | 3,885 | 3,075 | 5,101 | 4,423 | 4,797 | 4,417 | 5,020 | 4,243 | 5,801 | 5,488 | 5,446 | 6,575 | 7,031 | 5,388 | 4,610 | 4,521 | 5,305 | 6,095 | 6,273 | 5,179 | 6,857 | 8,089 | 5,211 | 7,551 | 5,773 | 5,739 | 3,512 | 6,035 | 6,920 | 8,084 | 5,021 | 7,786 | 5,163 | |||
| 4. | Israel |
8%
|
3,361 | 3,449 | 3,294 | 2,725 | 2,408 | 3,694 | 2,238 | 2,722 | 2,678 | 3,667 | 3,874 | 3,562 | 2,663 | 2,551 | 3,840 | 4,329 | 4,487 | 9,454 | 4,664 | 5,132 | 3,263 | 1,654 | 3,567 | 6,021 | 4,130 | 5,040 | 3,270 | 5,443 | 5,447 | 6,478 | 2,912 | 3,737 | 5,156 | 4,402 | 6,114 | 4,293 | 2,142 | 2,508 | 3,798 | 4,262 | 5,623 | 2,886 | 3,980 | 7,537 | 5,306 | 4,040 | 5,902 | 5,878 | 4,470 | 5,528 | |||
| 5. | United Kingdom |
8%
|
5,056 | 6,002 | 5,519 | 5,893 | 4,769 | 3,612 | 5,701 | 7,915 | 6,421 | 6,710 | 8,097 | 5,845 | 4,228 | 3,812 | 4,604 | 4,062 | 4,480 | 6,083 | 5,390 | 7,038 | 4,561 | 4,728 | 3,692 | 4,339 | 2,537 | 2,992 | 4,183 | 2,973 | 2,605 | 4,459 | 3,024 | 4,540 | 3,581 | 2,246 | 2,355 | 3,924 | 1,966 | 2,990 | 4,157 | 2,578 | 3,095 | 2,728 | 2,831 | 3,427 | 3,349 | 2,851 | 2,619 | 2,760 | 2,608 | 2,678 | |||
| 6. | Subscribers only |
7%
|
3,149 | 3,527 | 3,765 | 4,617 | 4,126 | 4,412 | 4,158 | 3,600 | 4,000 | 5,174 | 4,457 | 3,357 | 3,519 | 3,722 | 3,959 | 3,538 | 3,556 | 3,994 | 2,693 | 5,081 | 2,191 | 2,367 | 3,102 | 3,679 | 3,437 | 2,874 | 3,517 | 2,539 | 2,835 | 3,126 | 3,017 | 3,350 | 2,909 | 3,537 | 3,284 | 3,343 | 2,905 | 2,773 | 4,124 | 4,233 | 3,417 | 3,179 | 3,548 | 4,055 | 2,407 | 3,009 | 3,020 | 2,706 | 2,742 | 2,987 | |||
| 7. | Subscribers only |
6%
|
3,087 | 2,478 | 3,983 | 4,221 | 2,429 | 4,249 | 4,080 | 2,953 | 3,683 | 4,086 | 3,740 | 3,861 | 3,562 | 4,202 | 4,495 | 3,451 | 3,949 | 4,125 | 5,299 | 3,987 | 3,323 | 3,662 | 4,627 | 3,300 | 3,051 | 3,413 | 3,282 | 3,475 | 2,800 | 3,157 | 2,352 | 2,951 | 2,295 | 2,806 | 2,267 | 3,300 | 2,265 | 2,197 | 2,591 | 2,348 | 2,583 | 2,716 | 2,666 | 2,426 | 2,237 | 2,980 | 2,330 | 2,907 | 2,360 | 1,966 | |||
| 8. | India |
5%
|
834 | 904 | 1,197 | 1,488 | 1,469 | 1,509 | 1,354 | 1,415 | 1,852 | 1,551 | 1,476 | 1,526 | 1,428 | 1,439 | 2,079 | 1,632 | 2,000 | 2,133 | 1,835 | 2,004 | 2,266 | 2,438 | 2,417 | 2,196 | 2,423 | 1,888 | 3,216 | 2,424 | 2,417 | 2,421 | 2,435 | 3,444 | 3,016 | 2,988 | 2,667 | 2,856 | 3,017 | 3,071 | 3,458 | 2,826 | 3,572 | 3,737 | 3,792 | 3,727 | 3,860 | 3,470 | 3,723 | 4,009 | 3,798 | 3,332 | |||
| 9. | Subscribers only |
4%
|
781 | 977 | 1,169 | 1,308 | 977 | 1,112 | 1,588 | 712 | 1,377 | 2,109 | 3,597 | 9,519 | 6,521 | 1,596 | 1,893 | 1,320 | 862 | 3,396 | 1,858 | 1,428 | 1,779 | 1,465 | 1,409 | 1,300 | 1,303 | 2,536 | 2,704 | 1,028 | 1,667 | 1,337 | 1,363 | 1,883 | 1,472 | 2,198 | 1,349 | 807 | 1,378 | 1,342 | 1,919 | 1,618 | 1,507 | 1,371 | 1,199 | 2,589 | 1,060 | 1,814 | 1,870 | 2,990 | 2,460 | 1,432 | |||
| 10. | Subscribers only |
3%
|
993 | 1,088 | 1,830 | 1,450 | 1,054 | 1,611 | 1,629 | 1,771 | 1,885 | 1,775 | 2,032 | 1,759 | 1,945 | 1,335 | 1,731 | 1,698 | 1,361 | 1,097 | 1,857 | 1,326 | 1,404 | 1,338 | 1,477 | 1,630 | 1,550 | 1,498 | 2,060 | 1,679 | 1,730 | 1,991 | 1,534 | 1,242 | 1,267 | 1,600 | 1,732 | 1,556 | 1,946 | 1,606 | 2,071 | 1,269 | 1,299 | 1,490 | 1,869 | 1,234 | 1,123 | 1,978 | 1,632 | 1,098 | 1,885 | 1,583 | |||
| 11. | Subscribers only |
3%
|
587 | 953 | 1,117 | 982 | 730 | 1,159 | 1,391 | 461 | 1,533 | 769 | 997 | 441 | 837 | 1,036 | 1,662 | 1,492 | 626 | 1,541 | 1,955 | 1,219 | 1,154 | 1,716 | 1,314 | 1,676 | 1,539 | 1,565 | 2,001 | 1,516 | 1,223 | 1,147 | 1,227 | 2,704 | 1,861 | 1,554 | 2,188 | 1,293 | 2,027 | 2,091 | 1,949 | 1,731 | 2,707 | 1,922 | 2,827 | 2,322 | 2,278 | 2,243 | 2,031 | 1,108 | 2,783 | 1,082 | |||
| 12. | Subscribers only |
3%
|
1,196 | 1,296 | 1,281 | 1,361 | 1,594 | 1,472 | 1,520 | 1,720 | 1,534 | 1,535 | 1,644 | 1,581 | 1,283 | 1,368 | 1,324 | 1,877 | 1,364 | 1,406 | 2,206 | 1,596 | 1,686 | 1,739 | 1,967 | 1,811 | 1,341 | 1,862 | 1,492 | 1,477 | 1,120 | 1,186 | 964 | 1,412 | 1,012 | 1,029 | 615 | 1,439 | 883 | 641 | 756 | 740 | 1,900 | 886 | 1,022 | 933 | 915 | 1,073 | 1,219 | 1,024 | 1,020 | 971 | |||
| 13. | Singapore |
2%
|
959 | 1,401 | 3,066 | 1,789 | 1,511 | 1,040 | 825 | 177 | 3,118 | 2,192 | 1,691 | 2,167 | 2,749 | 1,476 | 1,402 | 73 | 449 | 1,844 | 1,645 | 1,047 | 1,934 | 2,673 | 673 | 1,822 | 1,910 | 1,123 | 1,122 | 2,468 | 495 | 626 | 877 | 639 | 765 | 872 | 847 | 912 | 537 | 565 | 1,042 | 564 | 707 | 742 | 431 | 1,301 | 993 | 591 | 706 | 329 | 878 | 769 | |||
| 14. | Subscribers only |
2%
|
582 | 599 | 660 | 954 | 693 | 742 | 752 | 814 | 776 | 949 | 660 | 661 | 531 | 825 | 895 | 574 | 943 | 693 | 809 | 953 | 491 | 954 | 777 | 810 | 605 | 942 | 1,257 | 620 | 802 | 711 | 720 | 1,461 | 681 | 1,224 | 779 | 963 | 838 | 1,084 | 962 | 888 | 1,024 | 1,153 | 1,041 | 1,021 | 855 | 1,015 | 1,113 | 1,140 | 816 | 1,062 | |||
| 15. | Subscribers only |
1%
|
534 | 471 | 550 | 649 | 635 | 653 | 630 | 691 | 670 | 625 | 644 | 827 | 565 | 698 | 709 | 696 | 697 | 777 | 751 | 836 | 829 | 650 | 713 | 801 | 757 | 599 | 781 | 628 | 822 | 882 | 946 | 734 | 582 | 631 | 775 | 785 | 1,063 | 594 | 660 | 711 | 751 | 809 | 828 | 784 | 657 | 850 | 747 | 871 | 923 | 644 | |||
| 16. | Subscribers only |
1%
|
1,076 | 1,265 | 1,529 | 1,389 | 780 | 842 | 843 | 576 | 912 | 690 | 666 | 549 | 854 | 634 | 721 | 775 | 682 | 814 | 842 | 766 | 832 | 785 | 797 | 747 | 691 | 746 | 712 | 811 | 865 | 699 | 1,218 | 565 | 600 | 791 | 675 | 444 | 498 | 304 | 508 | 396 | 235 | 408 | 188 | 302 | 445 | 312 | 399 | 602 | 243 | 229 | |||
| 17. | Subscribers only |
1%
|
94 | 280 | 163 | 447 | 104 | 299 | 534 | 964 | 875 | 371 | 615 | 693 | 381 | 704 | 808 | 639 | 271 | 251 | 237 | 685 | 150 | 445 | 344 | 328 | 568 | 819 | 534 | 495 | 472 | 540 | 436 | 343 | 795 | 331 | 400 | 412 | 916 | 503 | 401 | 639 | 619 | 934 | 1,053 | 1,594 | 1,958 | 1,213 | 1,938 | 1,399 | 1,357 | 1,324 | |||
| 18. | Subscribers only |
1%
|
300 | 455 | 1,218 | 836 | 634 | 585 | 744 | 518 | 792 | 386 | 971 | 677 | 987 | 671 | 702 | 324 | 582 | 978 | 872 | 431 | 519 | 734 | 659 | 736 | 518 | 738 | 755 | 675 | 840 | 784 | 537 | 584 | 684 | 402 | 476 | 431 | 532 | 598 | 314 | 432 | 755 | 531 | 640 | 303 | 630 | 779 | 1,092 | 674 | 612 | 614 | |||
| 19. | Subscribers only |
1%
|
289 | 206 | 469 | 260 | 397 | 417 | 379 | 368 | 266 | 296 | 233 | 470 | 203 | 332 | 552 | 313 | 443 | 280 | 368 | 216 | 361 | 290 | 285 | 402 | 459 | 500 | 459 | 521 | 372 | 541 | 325 | 403 | 496 | 342 | 155 | 303 | 394 | 305 | 454 | 445 | 913 | 345 | 483 | 252 | 357 | 194 | 464 | 475 | 383 | 427 | |||
| 20. | Subscribers only |
1%
|
278 | 415 | 437 | 256 | 235 | 252 | 281 | 308 | 250 | 370 | 795 | 181 | 296 | 316 | 743 | 267 | 493 | 205 | 391 | 173 | 465 | 319 | 557 | 265 | 275 | 505 | 627 | 145 | 254 | 372 | 523 | 498 | 530 | 435 | 183 | 271 | 95 | 219 | 355 | 200 | 267 | 399 | 468 | 482 | 138 | 222 | 112 | 149 | 144 | 162 | |||
| 21. | Mexico |
<1%
|
139 | 166 | 200 | 169 | 188 | 209 | 203 | 243 | 200 | 219 | 227 | 221 | 163 | 180 | 221 | 202 | 207 | 217 | 192 | 269 | 223 | 259 | 227 | 273 | 228 | 252 | 272 | 265 | 319 | 311 | 269 | 301 | 347 | 355 | 389 | 295 | 204 | 337 | 371 | 232 | 300 | 221 | 282 | 284 | 372 | 321 | 269 | 228 | 209 | 177 | |||
| 22. | Subscribers only |
<1%
|
348 | 249 | 321 | 282 | 281 | 403 | 162 | 192 | 236 | 345 | 321 | 352 | 573 | 284 | 337 | 264 | 171 | 217 | 333 | 191 | 177 | 284 | 266 | 209 | 327 | 226 | 393 | 220 | 248 | 274 | 70 | 55 | 81 | 169 | 84 | 298 | 199 | 67 | 108 | 126 | 121 | 55 | 81 | 86 | 55 | 69 | 148 | 126 | 91 | 112 | |||
| 23. | Subscribers only |
<1%
|
96 | 55 | 94 | 119 | 84 | 129 | 113 | 72 | 55 | 67 | 90 | 64 | 101 | 106 | 92 | 127 | 117 | 127 | 148 | 115 | 114 | 135 | 137 | 134 | 185 | 101 | 145 | 127 | 179 | 135 | 158 | 178 | 105 | 129 | 117 | 146 | 103 | 129 | 96 | 124 | 147 | 121 | 228 | 272 | 93 | 68 | 101 | 119 | 127 | 111 | |||
| 24. | Subscribers only |
<1%
|
142 | 41 | 25 | 29 | 14 | 41 | 30 | 60 | 83 | 55 | 70 | 162 | 57 | 131 | 130 | 8.52 | 34 | 103 | 52 | 37 | 67 | 92 | 84 | 126 | 50 | 41 | 71 | 49 | 142 | 73 | 58 | 126 | 88 | 194 | 137 | 293 | 121 | 166 | 127 | 49 | 31 | 112 | 75 | 147 | 143 | 122 | 127 | 117 | 145 | 109 | |||
| 25. | Subscribers only |
<1%
|
48 | 60 | 74 | 75 | 53 | 87 | 102 | 129 | 114 | 87 | 83 | 117 | 99 | 75 | 106 | 82 | 70 | 91 | 68 | 99 | 86 | 81 | 94 | 115 | 73 | 94 | 81 | 84 | 101 | 126 | 102 | 84 | 77 | 70 | 140 | 184 | 71 | 139 | 62 | 78 | 97 | 71 | 69 | 75 | 65 | 68 | 97 | 144 | 63 | 69 | |||
| 26. | Subscribers only |
<1%
|
167 | 23 | 78 | 5.70 | 74 | 203 | 26 | 131 | 57 | 97 | 23 | 107 | 116 | 94 | 116 | 136 | 23 | 67 | 188 | 69 | 965 | 64 | 0.20 | 6.21 | 371 | 0.15 | 4.96 | 298 | 0.87 | 54 | 3.06 | 6.78 | 3.78 | 19 | 3.47 | 52 | 149 | 6.01 | 7.56 | 7.90 | 142 | 5.36 | 4.96 | 9.51 | 6.30 | 7.32 | 11 | 17 | 4.15 | 8.97 | |||
| 27. | Subscribers only |
<1%
|
9.96 | 5.80 | 19 | 15 | 8.27 | 13 | 17 | 91 | 17 | 4.03 | 17 | 43 | 19 | 22 | 9.56 | 17 | 20 | 12 | 22 | 38 | 47 | 22 | 43 | 24 | 59 | 27 | 60 | 54 | 94 | 79 | 111 | 156 | 108 | 133 | 140 | 212 | 169 | 126 | 83 | 88 | 214 | 102 | 119 | 74 | 121 | 97 | 83 | 96 | 94 | 34 | |||
| 28. | Subscribers only |
<1%
|
13 | 26 | 26 | 26 | 22 | 28 | 40 | 26 | 36 | 40 | 27 | 41 | 11 | 20 | 40 | 38 | 38 | 37 | 47 | 43 | 45 | 37 | 55 | 25 | 36 | 27 | 34 | 25 | 31 | 30 | 39 | 33 | 46 | 60 | 33 | 35 | 29 | 44 | 42 | 46 | 41 | 52 | 38 | 47 | 51 | 48 | 40 | 41 | 17 | 33 | |||
| 29. | Subscribers only |
<1%
|
78 | 118 | 129 | 86 | 109 | 232 | 110 | 36 | 16 | 17 | 16 | 14 | 15 | 11 | 13 | 13 | 14 | 14 | 16 | 20 | 24 | 20 | 17 | 27 | 16 | 16 | 19 | 16 | 15 | 17 | 24 | 26 | 22 | 22 | 19 | 20 | 25 | 16 | 26 | 23 | 25 | 23 | 19 | 25 | 36 | 18 | 22 | 26 | 30 | 24 | |||
| 30. | Subscribers only |
<1%
|
14 | 22 | 38 | 26 | 26 | 21 | 26 | 29 | 29 | 30 | 24 | 31 | 32 | 37 | 32 | 18 | 21 | 23 | 25 | 52 | 30 | 28 | 25 | 41 | 31 | 30 | 51 | 41 | 38 | 43 | 22 | 37 | 42 | 31 | 32 | 22 | 14 | 24 | 37 | 54 | 39 | 20 | 38 | 36 | 36 | 29 | 35 | 34 | 27 | 16 | |||
| 31. | Subscribers only |
<1%
|
6.91 | 9.46 | 7.75 | 2.41 | 11 | 6.45 | 8.64 | 15 | 13 | 10 | 9.56 | 11 | 13 | 14 | 15 | 14 | 14 | 20 | 22 | 23 | 30 | 22 | 25 | 29 | 23 | 17 | 18 | 54 | 19 | 37 | 44 | 44 | 46 | 39 | 68 | 46 | 49 | 57 | 68 | 50 | 33 | 55 | 36 | 31 | 30 | 41 | 39 | 36 | 60 | 43 | |||
| 32. | Subscribers only |
<1%
|
2.01 | 2.34 | 7.89 | 1.01 | 34 | 11 | 49 | 33 | 31 | 20 | 18 | 3.81 | 20 | 1.53 | 5.95 | 12 | 23 | 15 | 15 | 12 | 22 | 20 | 26 | 29 | 21 | 21 | 18 | 33 | 32 | 23 | 50 | 33 | 21 | 23 | 33 | 26 | 41 | 38 | 45 | 57 | 38 | 52 | 54 | 39 | 40 | 45 | 50 | 59 | 53 | 34 | |||
| 33. | Subscribers only |
<1%
|
12 | 8.49 | 15 | 23 | 22 | 27 | 5.59 | 27 | 15 | 24 | 33 | 17 | 29 | 16 | 17 | 17 | 27 | 21 | 17 | 18 | 28 | 25 | 31 | 11 | 31 | 13 | 23 | 26 | 22 | 27 | 27 | 12 | 30 | 22 | 25 | 35 | 26 | 24 | 23 | 25 | 24 | 44 | 34 | 26 | 25 | 26 | 23 | 30 | 34 | 31 | |||
| 34. | South Africa |
<1%
|
0.37 | 1.48 | 6.31 | 13 | 15 | 7.13 | 25 | 15 | 13 | 18 | 8.44 | 16 | 15 | 7.39 | 18 | 20 | 26 | 9.51 | 26 | 12 | 19 | 11 | 15 | 10 | 23 | 20 | 26 | 21 | 30 | 19 | 33 | 38 | 13 | 26 | 21 | 17 | 16 | 19 | 11 | 25 | 25 | 22 | 22 | 31 | 30 | 22 | 32 | 27 | 30 | 27 | |||
| 35. | Subscribers only |
<1%
|
14 | 29 | 21 | 13 | 21 | 14 | 2.60 | 18 | 5.69 | 26 | 21 | 32 | 14 | 17 | 27 | 17 | 23 | 21 | 22 | 11 | 18 | 23 | 24 | 13 | 17 | 36 | 31 | 18 | 19 | 21 | 17 | 12 | 15 | 11 | 9.53 | 5.87 | 9.11 | 19 | 15 | 16 | 30 | 37 | 18 | 19 | 11 | 26 | 26 | 21 | 15 | 19 | |||
| 36. | Subscribers only |
<1%
|
30 | 6.40 | 11 | 5.57 | 2.26 | 7.75 | 5.71 | 5.72 | 33 | 7.92 | 5.91 | 9.64 | 9.14 | 1.60 | 6.84 | 9.86 | 9.08 | 11 | 34 | 16 | 22 | 23 | 22 | 23 | 57 | 25 | 18 | 11 | 24 | 29 | 21 | 5.02 | 19 | 31 | 25 | 28 | 59 | 23 | 20 | 13 | 6.03 | 28 | 14 | 13 | 13 | 25 | 26 | 7.53 | 22 | 18 | |||
| 37. | Subscribers only |
<1%
|
8.02 | 19 | 7.48 | 8.69 | 13 | 15 | 11 | 15 | 13 | 9.66 | 16 | 15 | 5.11 | 14 | 12 | 13 | 13 | 18 | 10 | 14 | 12 | 11 | 15 | 11 | 21 | 9.67 | 15 | 14 | 17 | 13 | 12 | 16 | 13 | 17 | 14 | 14 | 17 | 23 | 15 | 15 | 18 | 15 | 18 | 14 | 16 | 21 | 17 | 18 | 15 | 23 | |||
| 38. | Subscribers only |
<1%
|
17 | 6.17 | 12 | 11 | 9.02 | 9.93 | 8.62 | 10 | 13 | 11 | 11 | 11 | 17 | 11 | 16 | 19 | 13 | 11 | 9.96 | 15 | 16 | 14 | 8.63 | 10 | 11 | 16 | 19 | 18 | 7.41 | 15 | 8.67 | 10 | 21 | 5.90 | 15 | 7.40 | 11 | 12 | 12 | 15 | 15 | 15 | 17 | 20 | 11 | 42 | 14 | 15 | 14 | 8.25 | |||
| 39. | Subscribers only |
<1%
|
4.29 | 9.26 | 9.55 | 7.45 | 11 | 4.57 | 8.23 | 7.79 | 8.29 | 7.71 | 5.12 | 14 | 8.70 | 4.76 | 11 | 4.83 | 4.58 | 4.98 | 5.13 | 3.96 | 3.71 | 7.26 | 4.25 | 5.81 | 6.83 | 4.58 | 9.97 | 11 | 8.64 | 5.28 | 5.14 | 5.42 | 7.06 | 10 | 8.74 | 4.77 | 2.97 | 14 | 12 | 2.89 | 4.46 | 13 | 3.08 | 8.97 | 8.27 | 7.13 | 11 | 7.88 | 14 | 6.81 | |||
| 40. | Subscribers only |
<1%
|
0 | 0.63 | 0.53 | 0 | 2.56 | 4.50 | 8.19 | 0 | 0.27 | 4.90 | 0 | 9.32 | 2.66 | 4.04 | 0 | 0 | 0.44 | 8.91 | 5.95 | 3.21 | 5.45 | 12 | 10 | 2.21 | 12 | 6.68 | 12 | 6.87 | 15 | 6.36 | 8.84 | 15 | 16 | 10 | 18 | 15 | 17 | 11 | 6.83 | 4.82 | 19 | 5.78 | 17 | 9.93 | 9.80 | 1.38 | 12 | 16 | 1.95 | 3.76 | |||
| 41. | Subscribers only |
<1%
|
0 | 0.25 | 0.25 | 0 | 0.11 | 2.18 | 1.90 | 1.49 | 0 | 0.34 | 2.58 | 1.13 | 0 | 0.44 | 0.64 | 1.06 | 0.41 | 1.57 | 6.24 | 17 | 8.80 | 16 | 13 | 40 | 18 | 26 | 32 | 19 | 13 | 21 | 4.35 | 23 | 21 | 19 | 1.78 | 1.34 | 0.30 | 0.83 | 1.99 | 0 | 1.11 | 0.93 | 0 | 0.30 | 1.81 | 0 | 0.30 | 0.81 | 0.87 | 0.80 | |||
| 42. | Subscribers only |
<1%
|
3.11 | 0 | 3.57 | 0 | 2.64 | 2.08 | 12 | 3.27 | 0 | 2.51 | 3.00 | 4.76 | 4.98 | 1.50 | 3.05 | 2.49 | 1.49 | 5.07 | 1.00 | 2.49 | 2.51 | 1.88 | 11 | 5.77 | 8.66 | 0 | 3.02 | 9.15 | 0.61 | 9.59 | 5.57 | 5.48 | 3.36 | 3.20 | 3.53 | 14 | 5.42 | 3.55 | 3.98 | 11 | 5.38 | 5.80 | 14 | 3.91 | 0 | 0 | 0.25 | 1.70 | 4.63 | 1.29 | |||
| 43. | Subscribers only |
<1%
|
3.07 | 3.06 | 6.29 | 2.35 | 2.38 | 3.40 | 3.80 | 3.57 | 3.22 | 5.86 | 5.43 | 3.45 | 2.39 | 2.38 | 2.47 | 2.72 | 1.57 | 3.18 | 2.04 | 3.34 | 3.11 | 2.99 | 2.34 | 5.09 | 5.17 | 3.01 | 4.61 | 3.15 | 8.70 | 3.46 | 2.82 | 3.32 | 4.72 | 4.03 | 4.69 | 3.95 | 9.58 | 3.62 | 3.65 | 4.59 | 5.24 | 6.65 | 4.56 | 5.98 | 9.14 | 1.88 | 2.79 | 6.06 | 4.83 | 5.25 | |||
| 44. | Subscribers only |
<1%
|
3.70 | 1.53 | 3.29 | 3.76 | 3.05 | 2.09 | 1.42 | 3.45 | 3.52 | 2.73 | 1.81 | 3.51 | 2.80 | 3.06 | 4.71 | 3.77 | 5.48 | 3.07 | 4.13 | 0.96 | 1.62 | 2.36 | 1.65 | 5.51 | 3.60 | 0.07 | 3.92 | 1.18 | 1.89 | 3.08 | 1.21 | 3.05 | 1.68 | 6.18 | 3.39 | 3.81 | 2.39 | 1.23 | 2.93 | 2.14 | 1.77 | 4.34 | 5.15 | 2.23 | 0.39 | 11 | 8.04 | 5.47 | 3.85 | 7.29 | |||
| 45. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 4.99 | 3.32 | 3.90 | 6.32 | 4.76 | 8.14 | 6.08 | 5.59 | 4.74 | 6.06 | 7.12 | 6.22 | 6.61 | 5.31 | 4.36 | 6.01 | 6.02 | 7.19 | 6.24 | 4.48 | 8.20 | 7.49 | 7.35 | 7.16 | 6.99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0 | 0 | 0.11 | 0 | |||
| 46. | Subscribers only |
<1%
|
2.74 | 0.38 | 1.05 | 9.14 | 0.60 | 4.36 | 0.57 | 3.73 | 1.02 | 3.84 | 4.22 | 3.29 | 7.93 | 4.07 | 1.24 | 4.86 | 5.56 | 4.47 | 1.87 | 3.68 | 0.21 | 5.84 | 2.88 | 3.81 | 1.32 | 1.04 | 1.96 | 2.62 | 1.07 | 5.21 | 1.91 | 4.39 | 0.12 | 0.06 | 1.93 | 6.56 | 4.77 | 0.73 | 1.12 | 0 | 0.89 | 4.09 | 1.89 | 0.23 | 5.28 | 3.05 | 3.24 | 1.60 | 2.11 | 3.15 | |||
| 47. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 0 | 10 | 17 | 14 | 2.24 | 6.93 | 4.64 | 3.55 | 0 | 6.13 | 9.51 | 6.17 | 6.03 | 0 | 7.40 | 16 | 0 | 0 | 4.01 | 0 | 0 | 3.84 | 3.04 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 48. | Subscribers only |
<1%
|
0.12 | 0.01 | 0.01 | 0.04 | 0.08 | 0.04 | 0 | 0.01 | 0 | 0 | 0.19 | 0.01 | 0 | 0 | 0 | 0.03 | 0.08 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0.12 | 0 | 0.06 | 0 | 0 | 0.08 | 1.62 | 5.84 | 3.97 | 6.49 | 7.74 | 5.19 | 7.57 | 4.64 | 6.72 | 7.01 | 6.40 | 6.84 | 5.41 | 5.12 | 4.64 | 0 | 0.04 | |||
| 49. | Subscribers only |
<1%
|
0.60 | 0.14 | 3.95 | 1.29 | 0.72 | 1.14 | 1.55 | 5.43 | 2.52 | 1.78 | 5.24 | 0.62 | 3.94 | 3.26 | 2.06 | 2.50 | 2.50 | 2.80 | 3.58 | 4.01 | 2.27 | 2.09 | 0.83 | 1.61 | 0.43 | 4.33 | 2.73 | 3.91 | 2.66 | 1.87 | 1.59 | 0.98 | 1.03 | 0.64 | 2.31 | 1.68 | 1.51 | 0.40 | 0.38 | 0 | 0.35 | 0.20 | 1.10 | 0 | 0 | 0 | 0 | 0 | 0.80 | 0 | |||
| 50. | Subscribers only |
<1%
|
2.00 | 0.61 | 0 | 0.49 | 1.46 | 0.11 | 2.65 | 0.69 | 1.26 | 0.84 | 1.22 | 1.45 | 3.05 | 0.06 | 1.21 | 1.75 | 1.34 | 0.92 | 0.67 | 2.89 | 1.02 | 1.46 | 3.17 | 1.67 | 1.52 | 0 | 0 | 2.94 | 0.09 | 2.13 | 1.29 | 0.91 | 0.78 | 1.61 | 1.91 | 1.52 | 1.81 | 1.15 | 1.48 | 2.09 | 0.58 | 2.43 | 1.56 | 1.89 | 1.03 | 1.87 | 2.41 | 0.38 | 1.05 | 1.59 | |||
| 51. | Subscribers only |
<1%
|
1.30 | 1.08 | 1.04 | 0.76 | 1.90 | 2.10 | 1.49 | 1.29 | 1.18 | 1.28 | 1.00 | 0.93 | 1.32 | 1.49 | 1.07 | 0.61 | 0.83 | 2.23 | 1.08 | 0.89 | 1.30 | 1.14 | 1.56 | 0.77 | 1.84 | 0.67 | 2.08 | 0.76 | 1.26 | 1.02 | 1.18 | 2.34 | 0.83 | 0.94 | 1.55 | 1.36 | 1.28 | 2.06 | 1.67 | 1.87 | 1.24 | 1.73 | 1.43 | 0.83 | 0.84 | 0.30 | 0.54 | 0.68 | 1.74 | 0.28 | |||
| 52. | Subscribers only |
<1%
|
0.42 | 0.48 | 0.69 | 0.08 | 0.35 | 0.40 | 0.63 | 1.11 | 0.54 | 0.98 | 0.84 | 0.54 | 0.16 | 1.10 | 0.86 | 0.75 | 0.30 | 1.40 | 0.85 | 0.42 | 1.03 | 1.11 | 0.85 | 0.47 | 0.48 | 0.52 | 0.68 | 0.52 | 0.24 | 1.87 | 0.42 | 0.43 | 1.70 | 0.64 | 0.54 | 1.21 | 3.68 | 0.05 | 0.58 | 0.30 | 2.04 | 0.69 | 0.93 | 2.22 | 1.53 | 1.77 | 1.64 | 0.67 | 0 | 1.31 | |||
| 53. | Subscribers only |
<1%
|
0.80 | 0.80 | 0.28 | 0 | 0.75 | 0 | 0.22 | 0.76 | 1.41 | 0.86 | 1.90 | 0 | 0.70 | 0.70 | 1.00 | 0 | 1.42 | 0.70 | 0.44 | 0.70 | 0.70 | 0.73 | 0 | 0.37 | 0.73 | 0.73 | 0.76 | 1.63 | 1.64 | 0.73 | 0.73 | 2.32 | 0.76 | 0.42 | 1.83 | 0.79 | 0.05 | 3.83 | 0.93 | 2.07 | 0.55 | 1.21 | 0.83 | 0.77 | 0.02 | 0.76 | 0.83 | 0.02 | 0.04 | 0.77 | |||
| 54. | Subscribers only |
<1%
|
0.35 | 0.20 | 0.24 | 0.18 | 0.12 | 0.10 | 0.36 | 0.27 | 0 | 0.36 | 0.54 | 0.06 | 0.22 | 0.13 | 0.11 | 0.56 | 0.45 | 0.46 | 0.24 | 0.52 | 0.64 | 0.48 | 0.58 | 0.11 | 0.27 | 0.46 | 0.02 | 0.39 | 0.80 | 0.07 | 0.32 | 0.21 | 0.38 | 0.22 | 0.45 | 0.36 | 1.38 | 0.94 | 2.24 | 1.73 | 1.50 | 5.12 | 4.16 | 2.10 | 0.63 | 1.20 | 0.58 | 0.16 | 3.25 | 1.08 | |||
| 55. | Panama |
<1%
|
1.43 | 0.17 | 3.41 | 0.50 | 0.87 | 2.29 | 0 | 1.28 | 0.71 | 0.92 | 0.75 | 0 | 0.58 | 1.02 | 1.89 | 0.94 | 0.78 | 0.42 | 1.00 | 0 | 0 | 0.43 | 0 | 1.61 | 3.08 | 0.24 | 0.53 | 1.41 | 1.35 | 0.90 | 0.19 | 0.31 | 1.03 | 0 | 0 | 0 | 0 | 0.03 | 0.93 | 0.93 | 0 | 0 | 0 | 0 | 0 | 0 | 0.95 | 0 | 0 | 0 | |||
| 56. | Subscribers only |
<1%
|
0.32 | 0.65 | 0 | 0 | 0.35 | 0.32 | 0.76 | 0.35 | 0.34 | 0.33 | 0 | 0 | 0.32 | 1.43 | 0 | 0 | 0 | 0.72 | 0.36 | 0.41 | 0.58 | 0 | 0 | 1.08 | 0.54 | 1.35 | 1.21 | 0.02 | 1.04 | 0.70 | 0.70 | 0.60 | 1.07 | 0.60 | 0.70 | 0.60 | 0.64 | 3.32 | 0.60 | 1.10 | 0.30 | 0.60 | 1.30 | 0 | 0.30 | 1.15 | 0.83 | 0.60 | 1.58 | 0.60 | |||
| 57. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 7.22 | 0 | 0 | 0 | 4.02 | 0 | 0.49 | 0.30 | 0 | 0.10 | 0 | 0 | 0 | 0 | 1.96 | 0 | 0 | 0 | 1.75 | 4.44 | 1.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.46 | 0 | 0.95 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 58. | Subscribers only |
<1%
|
0.46 | 0.45 | 0 | 0 | 0.02 | 0 | 0.70 | 0 | 0 | 0 | 0.70 | 0 | 0 | 0 | 0 | 0.90 | 0 | 0.02 | 0.40 | 0 | 0.65 | 0.65 | 0 | 0 | 0.90 | 0.47 | 0.35 | 0 | 0.60 | 0.93 | 0.03 | 0.54 | 0.09 | 0.35 | 0.15 | 0.06 | 1.13 | 0.93 | 0.23 | 1.53 | 0.15 | 0.13 | 1.35 | 0.59 | 0.31 | 0.32 | 1.68 | 0 | 1.48 | 0.43 | |||
| 59. | Subscribers only |
<1%
|
0.02 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.07 | 0 | 0.26 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 1.29 | 0 | 0 | 0 | 0 | 0 | 0.09 | 0.05 | 0.26 | 0.05 | 0 | 0 | 16 | 0 | 0.03 | 0 | 0.11 | 0 | 0 | 0 | 0 | |||
| 60. | Subscribers only |
<1%
|
0 | 0 | 0.18 | 0.09 | 0 | 0 | 0.13 | 0 | 1.15 | 0.08 | 0.06 | 0 | 0 | 1.51 | 0 | 0.89 | 2.29 | 0 | 0 | 0.30 | 0.14 | 0 | 0.03 | 0 | 0 | 0.04 | 0.14 | 0 | 0.08 | 0.85 | 0 | 0.59 | 0.04 | 0 | 0.18 | 0 | 0.15 | 0 | 0 | 0 | 0 | 0 | 1.01 | 3.14 | 0.81 | 2.69 | 0.21 | 0 | 0.26 | 0.02 | |||
| 61. | Subscribers only |
<1%
|
0 | 0.43 | 0 | 0 | 0.26 | 0.08 | 0 | 0.78 | 0.47 | 0.32 | 0 | 0 | 0.20 | 0 | 0.67 | 0 | 0 | 0.03 | 0 | 0 | 0.06 | 0 | 0 | 0.19 | 0.19 | 0 | 0.07 | 0 | 0 | 0.08 | 0.45 | 0.16 | 0.45 | 0.45 | 0 | 0 | 0.87 | 0 | 0 | 0.76 | 0.34 | 0.03 | 0.20 | 0 | 0.42 | 0.26 | 0.22 | 0.44 | 0.79 | 0.45 | |||
| 62. | Subscribers only |
<1%
|
0.39 | 0.73 | 0.47 | 0.25 | 0.57 | 0.88 | 0.92 | 0 | 0.61 | 1.23 | 0.55 | 0.85 | 0.71 | 0.12 | 0.03 | 0.94 | 0.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 63. | Subscribers only |
<1%
|
0.01 | 0.03 | 0.34 | 0.21 | 0.07 | 0.31 | 0.21 | 0.11 | 0.36 | 0 | 0.26 | 0.22 | 0 | 0.28 | 0.02 | 0 | 0.21 | 0.21 | 0.41 | 0 | 0.29 | 0 | 0.21 | 0 | 0.21 | 0 | 0.21 | 0.21 | 0.11 | 0 | 0.21 | 0 | 0.10 | 0 | 0 | 0 | 0 | 0.21 | 0 | 0.33 | 1.87 | 0.21 | 0 | 0.68 | 0 | 0.45 | 0.05 | 0 | 0 | 0.03 | |||
| 64. | Subscribers only |
<1%
|
0.03 | 0.06 | 0.02 | 0.08 | 0.08 | 0.08 | 0.35 | 0.04 | 0.10 | 0.47 | 0.02 | 0.12 | 0.39 | 0.08 | 0.02 | 0.14 | 0.49 | 0.40 | 0.10 | 0.20 | 0.14 | 0 | 0.05 | 0.10 | 0.03 | 0 | 0.43 | 0.05 | 0 | 0.08 | 0.07 | 0.38 | 0 | 0.13 | 0.34 | 0 | 0 | 0.36 | 0.30 | 0.73 | 0 | 0.13 | 0.09 | 0.05 | 0.11 | 0.09 | 0.07 | 0.08 | 0.47 | 0.05 | |||
| 65. | Subscribers only |
<1%
|
0.43 | 0.05 | 0.19 | 0.58 | 0.24 | 0.07 | 0.18 | 0 | 0.20 | 1.06 | 0.11 | 0.09 | 0.32 | 1.03 | 0.97 | 0.94 | 0.71 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | |||
| 66. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 67. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.12 | 0.06 | 0 | 2.04 | 0 | 0.11 | 0 | 2.09 | 0.11 | 0 | 0.36 | |||
| 68. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0.68 | 0.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0 | 0.04 | 0 | 0.02 | 0.13 | 0.10 | 0.36 | 0.09 | 0 | 0.05 | 0.59 | 0.13 | 0 | 0.03 | 0 | 0.31 | 0.84 | 0.05 | 0 | 0 | 0 | 0 | 0.14 | |||
| 69. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0.88 | 0 | 0 | 0 | 2.62 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 70. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 71. | Subscribers only |
<1%
|
0.38 | 0.17 | 0 | 0.03 | 0 | 0.13 | 0 | 0 | 0 | 0 | 0.07 | 0 | 0 | 0.11 | 0.17 | 0.50 | 0.07 | 0.05 | 0.16 | 0 | 0.50 | 0.05 | 0 | 0 | 0.48 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0.20 | 0 | 0 | 0 | 0 | 0.11 | 0.04 | 0 | 0 | |||
| 72. | Subscribers only |
<1%
|
0.03 | 0 | 0.31 | 0.12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.22 | 0 | 0.15 | 0.21 | 0.05 | 0.13 | 0.15 | 0.15 | 0.09 | 0 | 0 | 0.03 | 0.12 | 0.13 | 0.08 | 0.07 | 0.13 | 0.05 | 0.09 | 0 | 0 | 0.03 | 0 | 0.02 | 0 | 0.12 | 0 | 0.04 | 0.04 | 0 | 0.16 | 0 | 0.06 | 0.03 | 0 | 0.03 | 0.22 | 0 | |||
| 73. | Subscribers only |
<1%
|
0.30 | 0.27 | 0 | 0.14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.51 | 0.26 | 0.11 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0.29 | 0 | 0.06 | 0 | 0 | 0 | 0.02 | 0.14 | 0.63 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.14 | 0 | 0 | |||
| 74. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.73 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 75. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0.40 | 0.66 | 0.42 | 0.28 | 0.25 | |||
| 76. | Subscribers only |
<1%
|
0 | 0 | 0.33 | 0 | 0 | 0 | 0 | 0.31 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.24 | 0 | 0 | 0 | 0 | 1.48 | 0 | 0 | 0 | 0 | 0 | |||
| 77. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.73 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.25 | 0 | 0.05 | 0 | 0.02 | 0.03 | 0.04 | 0 | 0 | 0 | 0.03 | 0 | |||
| 78. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.40 | 0 | 0.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0.10 | 0 | 0.24 | 0 | 0 | 0.03 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0.10 | 0 | 0 | 0 | 0.10 | 0 | 0.07 | 0 | 0 | 0 | |||
| 79. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 1.49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 80. | Subscribers only |
<1%
|
0.04 | 0.00 | 0 | 0 | 0.07 | 0.04 | 0.04 | 0.30 | 0.04 | 0 | 0.03 | 0.04 | 0 | 0 | 0.03 | 0.05 | 0.06 | 0 | 0 | 0.05 | 0.02 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 81. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.72 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | |||
| 82. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0.20 | 0 | 0 | 0.16 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0.21 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 83. | Subscribers only |
<1%
|
0.14 | 0.07 | 0.08 | 0.05 | 0.05 | 0.05 | 0 | 0.04 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 84. | Subscribers only |
<1%
|
0 | 0 | 0 | 0.03 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0.04 | 0 | 0.04 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | |||
| 85. | Subscribers only |
<1%
|
0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0.02 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0.18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 86. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0.22 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 87. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 88. | Subscribers only |
<1%
|
0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0.05 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 89. | Sri Lanka |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0.12 | 0 | 0 | 0 | 0.02 | 0.10 | 0 | 0 | 0 | 0 | 0 | |||
| 90. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 91. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.11 | |||
| 92. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.14 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0.02 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 93. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 | 0 | 0.12 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | |||
| 94. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 95. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 | 0.08 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 96. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | |||
| 97. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 98. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | |||
| 99. | Subscribers only |
<1%
|
0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 100. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 101. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0.02 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 102. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 103. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 104. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 105. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 106. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 107. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 108. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 109. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 110. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 111. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 112. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 113. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 114. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 115. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | |||
| 116. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 117. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Import | Export | Descripción |
|---|---|---|
| 30 | 30 | Pharmaceutical products |
| 3001 | 3001 | 0: Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included |
| 3002 | 3002 | Pharmaceutical products: Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: |
| 3003 | 3003 | 0: Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale |
| 3004 | 3004 | 0: Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale |
| 3005 | 3005 | 0: Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes |
| 3006 | 3006 | 0: Pharmaceutical goods specified in note 4 to this chapter |
| 31 | 31 | Fertilizers |
| 32 | 32 | Tanning or dyeing extracts; dyes, pigments, paints, varnishes, putty and mastics |
| 33 | 33 | Essential oils and resinoids; perfumery, cosmetic or toilet preparations |
| 34 | 34 | Soap, organic surface-active agents, washing preparations, lubricating preparations, artificial waxes, prepared waxes, polishing or scouring preparations, candles and similar articles, modeling pastes, 'dental waxes' and dental preparations with a basis of plaster |
| 35 | 35 | Albuminoidal substances; modified starches; glues; enzymes |
| 36 | 36 | Explosives; pyrotechnic products; matches; pyrophoric alloys; certain combustible preparations |
| 37 | 37 | Photographic or cinematographic goods |
| 38 | 38 | Miscellaneous chemical products |
| 39 | 39 | Plastics and articles thereof |